Safety and Efficacy of a Subunit Vaccine against Flu Containing Polyoxidonium Systematic Review and Meta-Analysis of Clinical Trials

Safety and Efficacy of a Subunit Vaccine against Flu Containing Polyoxidonium Systematic Review and Meta-Analysis of Clinical Trials

The review presents a clinical expert meta-analysis of compliance with the basic requirements for safety and efficacy Of subunit influenza vaccine containing polymer Polyoxidonium (PO) as an adjuvant (PO-AG). The results of the meta-analysis convincingly demonstrate that a reduced HA dose in combina...

Full description

Bibliographic Details
Main Author:	R. Kompier
Format:	Article
Language:	Russian
Published:	Numikom LLC 2018-09-01
Series:	Эпидемиология и вакцинопрофилактика
Subjects:	influenza vaccine grippol polyoxidonium
Online Access:	https://www.epidemvac.ru/jour/article/view/564

Similar Items

Review of Grippol Family Vaccine Studies and Modern Adjuvant Development
by: A. V. Karaulov, et al.
Published: (2019-09-01)

SAFETY AND IMMUNOLOGIC EFFICACY OF COMBINED IMMUNIZATION IN CHILDREN AGED 6—7 YEARS WITH VACCINES FROM THE NATIONAL CALENDAR OF PROPHYLACTICS VACCINES
by: I. V. Konovalov, et al.
Published: (2015-08-01)

The effects of synthetic immunostimulator polyoxidonium on methotrexate treatment in rats with adjuvant arthritis
by: Jozef Rovenský, et al.
Published: (2011-12-01)

THE RESULTS OF STUDY OF THE LEVELS OF SPECIFIC ANTIBODIES TO THE COMBINED INJECTION VACCINES AGAINST INFLUENZA, MEASLES, RUBELLA AND MUMPS AND DT IN CHILDREN WITH CHRONIC PHYSICAL ILLNESS
by: S. M. Haritе, et al.
Published: (2015-08-01)

Results of a clinical study of the influenza tetravalent inactivated subunit adjuvant vaccine Grippol Quadrivalent in children aged 6 months to 5 years (inclusive)
by: Viktor V. Romanenko, et al.
Published: (2024-07-01)

Comparative Assessment of Reactogenicity and Immunogenicity of Commercial Influenza Inactivated Vaccines: Polymer-Subunit Grippol plus, Subunit Influvac, Split Vaccine Waxigrip
by: S. M. Kharit, et al.
Published: (2017-04-01)

Application of Polyoxidonium in the Mixed Treatment of Experimental Plague Generalized Forms
by: T. A. Bondareva, et al.
Published: (2009-02-01)

СLINICAL AND IMMUNOLOGICAL EFFICIENCY OF IMUNOFAN AND POLYOXIDONIUM IN COMBINED THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA
by: L. R. Mukhamadieva, et al.
Published: (2014-07-01)

Effects of the vaccine "Grippol" on resistance of mice after irradiation by protons
by: Ivanov А.А., et al.
Published: (2015-12-01)

The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study
by: Sergey V Efimov, et al.
Published: (2021-03-01)

Enhancement of the Yersinia pestis EV NIIEG Vaccine Srain Immunogenic and Protective Activity under Cultivation with Azoxymer Bromide (Polyoxidonium)
by: T. N. Shchukovskaya, et al.
Published: (2022-01-01)

Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study
by: Sergey V Efimov, et al.
Published: (2021-06-01)

THE EFFECTIVENESS OF THE TEMPORARY ROOT FILLINGS BASED ON POLYOXIDONIUM THE TREATMENT OF DESTRUCTIVE FORMS OF SECONDARY APICAL PERIODONTITIS
by: A. V. Samoylenko, et al.
Published: (2016-03-01)

Do We Still Need to Vaccinate Patients Against Flu After the Flu Infection?
by: Dilan Yağmur KUTLAY, et al.
Published: (2024-08-01)

Revisiting the Safety of Vaccination against the Flu in Elderly Patients
by: O. N. Tkacheva, et al.
Published: (2018-12-01)

Phase I Clinical Study of the Subunit Betulin-Adjuvanted Tetravalent Candidate Influenza Vaccine TetraFluBet
by: Igor Krasilnikov, et al.
Published: (2024-09-01)

The role of polyoxidonium as immunomodulating and immunoadjuvant agent in flu prevention
by: L. V. Luss
Published: (2013-12-01)

Results of Clinical Trials of the First Russian 4-valent Flu Vaccine
by: D. A. Lioznov
Published: (2018-09-01)

Immunorehabilitation Children with Impaired Health Status
by: O. V. Shamsheva, et al.
Published: (2016-06-01)

100 Years after the Spanish Flu Pandemic. The Evolution of the Influenza Virus and the Development of the Flu Vaccine
by: N. I. Briko
Published: (2018-09-01)

"THE INCIDENCE OF INFLUENZA LIKE ILLNESS AND DETERMINATION OF THE EFFICACY OF FLU VACCINE IN IRANIAN PILGRIMS DURING HAJJ PILGRIMAGE"
by: SM. Razavy, et al.
Published: (2004-11-01)

SAFETY ASSESSMENT OF TWO SUBUNIT INFLUENZA VACCINES IN CHILDREN WITH A BURDENED ALLERGOANAMNEZ
by: M. G. Galitskaya, et al.
Published: (2015-08-01)

Which Srategy will stop Flu
by: O. V. Shamsheva
Published: (2016-11-01)

Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine. [version 1; peer review: 2 approved]
by: Susanna Kharit, et al.
Published: (2022-03-01)

Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine. [version 2; peer review: 2 approved]
by: Susanna Kharit, et al.
Published: (2022-11-01)

Experience in Organizing in Metropolis Mobile Immunization to Vaccinate Adults against Flu
by: O. V. Filippov, et al.
Published: (2017-08-01)

Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us?
by: Iván Sanz-Muñoz, et al.
Published: (2025-02-01)

Flu Vaccination Coverage in 2020 in the Baixo Vouga Health Centre Group in Portugal
by: Filipe Prazeres, et al.
Published: (2021-05-01)

Effect of immunoadjuvants on the disease course in patients with operable breast cancer
by: M. M. Vasilyeva, et al.
Published: (2019-02-01)

THE ROLE OF MODERN IMMUNOMODULATORS IN TREATMENT AND PREVENTION OF UPPER RESPIRATORY TRACT AND EAR DISEASES
by: A. A. Krivopalov, et al.
Published: (2017-11-01)

Immunomodulatory therapy in ENT practice
by: D. M. Mustafaev, et al.
Published: (2016-12-01)

ON THE ISSUE OF CHANGING THE MORPHOLOGY OF THE SPLEEN IN NEMATODOSES IN MICE DURING IMMUNOSTIMULATION
by: Olga B. Zhdanova, et al.
Published: (2023-06-01)

T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine
by: Anna Schmidt, et al.
Published: (2021-01-01)

FluB-RAM and FluB-RANS: Genome Rearrangement as Safe and Efficacious Live Attenuated Influenza B Virus Vaccines
by: Stivalis Cardenas-Garcia, et al.
Published: (2021-08-01)

Cell culture-derived flu vaccine: Present and future
by: Alberto Pérez Rubio, et al.
Published: (2018-08-01)

Bird flu : a rising pandemic in Asia and beyond? /
by: Tambyah, Paul, et al.
Published: (2006)

Peculiarities of immunological status and facilities of immunocorrection of recidivous herpetic stomatitis
by: R. A. Belovolova, et al.
Published: (2010-03-01)

The value of immunomodulatory therapy (use of vaginal suppositories) in treatment of HPV-associated neoplasia
by: I N Kononova, et al.
Published: (2014-10-01)

A comprehensive approach to the treatment of septic pelvic inflammatory disease using immunomodulatory therapy
by: I A Lapina, et al.
Published: (2016-12-01)

Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort Study
by: Daniel Modin, et al.
Published: (2022-03-01)